1-3 of 3
Darci Zblewski, RN, CNP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Baseline Spleen Size and Mutations Involving ASXL1 and SRSF2 Predict Survival and Treatment Response In JAK Inhibitor Treated Myelofibrosis Patients

Animesh Pardanani, MBBS, PhD, Ramy A Abdelrahman, MBBCh, Kebede Begna, MD, Darci Zblewski, RN, CNP, Aref Al-Kali, MD, Mrinal M. Patnaik, MBBS, William Hogan, MD, Terra L Lasho, MT, (ASCP), Christy Finke, BS, Curtis A. Hanson, MD, Mark R. Litzow, MD, Ayalew Tefferi, MD
Journal: Blood
Blood (2013) 122 (21): 4048.
https://doi.org/10.1182/blood.V122.21.4048.4048
Published: 2013
Journal Articles

Retrospective Comparison Of Survival and Leukemic Transformation In Myelofibrosis Patients Treated With Ruxolitinib Versus Momelotinib Versus Fedratinib Versus Pomalidomide

Animesh Pardanani, MBBS, PhD, Ramy A. Abdelrahman, MBBCh, Kebede Begna, MD, Darci Zblewski, RN, CNP, Aref Al-Kali, MD, Mrinal M. Patnaik, MBBS, William Hogan, MD, Curtis A. Hanson, MD, Mark R. Litzow, MD, Ayalew Tefferi, MD
Journal: Blood
Blood (2013) 122 (21): 4049.
https://doi.org/10.1182/blood.V122.21.4049.4049
Published: 2013
Journal Articles

Clonal Evolution As Determined By Sequential Bone Marrow Karyotype Analysis During JAK Inhibitor Therapy For Myelofibrosis: Impact On Treatment Response and Overall and Leukemia-Free Survival

Ramy A. Abdelrahman, MBBCh, Kebede Begna, MD, Darci Zblewski, RN, CNP, Aref Al-Kali, MD, Mrinal M. Patnaik, MBBS, William Hogan, MD, Ryan A Knudson, Rhett P Ketterling, Curtis A. Hanson, MD, Mark R. Litzow, MD, Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD
Journal: Blood
Blood (2013) 122 (21): 2821.
https://doi.org/10.1182/blood.V122.21.2821.2821
Published: 2013